Hamden, CT, United States of America

Ellalahewage Kumarasinghe

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharmaceuticals Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellalahewage Kumarasinghe. Retrieved from https://idiyas.com/inventor/ellalahewage-kumarasinghe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ellalahewage Kumarasinghe

Introduction

Ellalahewage Kumarasinghe is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on indane acetic acid derivatives. His research focuses on developing compounds that can aid in the treatment of various diseases.

Latest Patents

Kumarasinghe holds a patent for "Indane acetic acid derivatives and their use as pharmaceutical agents." This invention relates to novel indane acetic acid derivatives that are useful in treating diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The pharmaceutical compositions containing these compounds represent a promising advancement in medical treatments.

Career Highlights

Kumarasinghe is currently employed at Bayer Pharmaceuticals Corporation, where he continues to contribute to pharmaceutical research and development. His work has the potential to impact the lives of many individuals suffering from chronic diseases.

Collaborations

Some of his notable coworkers include Philip L. Wickens and Louis-David Cantin, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Ellalahewage Kumarasinghe's innovative work in developing pharmaceutical agents showcases his dedication to improving healthcare solutions. His contributions are vital in the ongoing fight against chronic diseases, and his patent reflects the potential for significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…